BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation...
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin BARDA and its partner Mapp Biopharmaceutical Inc. will explore the potential of a new...
View ArticleMappBio Announces Contract with BARDA for Sudan Ebolavirus Medical...
MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure September 28, 2018 – (SAN DIEGO, CA) – Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been awarded...
View ArticleExperimental antibody ‘cocktail’ protects animals from three deadly Ebola...
Public Release The post Experimental antibody ‘cocktail’ protects animals from three deadly Ebola viruses appeared first on Mapp Biopharmaceutical, Inc..
View ArticleMappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical...
MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure June 11, 2019 – (SAN DIEGO, CA) – Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been...
View ArticleASPR awards $110 million to advance development, procure therapeutic for...
ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus The Administration for Strategic Preparedness and Response (ASPR) today announced a $109.8 million...
View ArticleBARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the...
BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease To further enhance preparedness against health security threats,...
View ArticleBARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the...
BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease As a part of ongoing national preparedness efforts against filoviruses, BARDA...
View ArticleNew human trials for novel antibody offer hope for immediate protection...
New human trials for novel antibody offer hope for immediate protection against deadly Nipah 3 July 2024; OSLO; CALIFORNIA; Twenty-five years after the first human outbreak of Nipah virus, a novel...
View Article